Search - tctmd.com

Displaying 1 - 20 of 45

Sort: Relevancy | Date

News Daily News

No Clear Risk of Dementia After TIA: Framingham Heart Study

L.A. McKeown

July 10, 2025

No Change in HF Outcomes When Private Equity Buys the Hospital

News Daily News

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Michael O'Riordan

June 16, 2025

News Daily News

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

L.A. McKeown

January 31, 2025

News Daily News

Aspirin Use for Primary Prevention Declining in US: NHANES

Michael O'Riordan

January 24, 2025

News Daily News

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Michael O'Riordan

January 03, 2025

News Daily News

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

L.A. McKeown

October 09, 2024

News Daily News

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Yael L. Maxwell

August 01, 2024

News Daily News

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

L.A. McKeown

June 18, 2024

News Daily News

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

L.A. McKeown

June 05, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Daily News

Don’t Avoid Statins in Elderly, Frail Patients: Two Retrospective Studies Argue

Yael L. Maxwell

December 15, 2023

News Daily News

Statin Use Has Plateaued in US Primary Prevention Patients

Michael O'Riordan

December 05, 2023

News Daily News

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

Michael O'Riordan

November 21, 2023

News Daily News

Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF

Todd Neale

March 15, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Daily News

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Michael O'Riordan

December 14, 2022

News Daily News

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Michael O'Riordan

November 29, 2022

News Daily News

New Biomarker-Based Risk Score Performs Well in ACS

Michael O'Riordan

October 25, 2022

News Daily News

COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review

Todd Neale

October 12, 2022

Advertisement

No Clear Risk of Dementia After TIA: Framingham Heart Study

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

Aspirin Use for Primary Prevention Declining in US: NHANES

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Top Endovascular News of 2023

Don’t Avoid Statins in Elderly, Frail Patients: Two Retrospective Studies Argue

Statin Use Has Plateaued in US Primary Prevention Patients

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

New Biomarker-Based Risk Score Performs Well in ACS

COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content